CASI Pharmaceuticals, Inc. (CASIF): Weighted Average Diluted Shares
18.54M
Year ended 2025-12-31
+10.7%
3-year compound annual growth
+10.9%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 18.54M | +20.8% | 2026-05-15, From 2025-01-01 |
| 2024-12-31 | 15.34M | +14.8% | 2026-05-15, From 2024-01-01 |
| 2023-12-31 | 13.36M | -2.1% | 2026-05-15, From 2023-01-01 |
| 2022-12-31 | 13.65M | +0.3% | 2025-03-31, From 2022-01-01 |
| 2021-12-31 | 13.61M | +23.2% | 2024-03-28, From 2021-01-01 |
| 2020-12-31 | 11.05M | n/a | 2023-04-26, From 2020-01-01 |